Treace Medical Concepts (TMCI) EBITDA Margin (2020 - 2026)
Treace Medical Concepts (TMCI) reported EBITDA Margin of 38.26% for Q1 2026, down 790.0% on a YoY basis from 5.55% in Q1 2025, and down 154.35% quarter-over-quarter from 15.04% in Q4 2025.
Treace Medical Concepts (TMCI) EBITDA Margin (2020 - 2026) Analysis & Trends
Treace Medical Concepts has reported EBITDA Margin for 7 years, with the latest figure at 38.26% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin fell 790.0% year-over-year to 38.26%; the trailing twelve-month figure through Mar 2026 stood at 29.48% (down 434.0% YoY), and the FY2025 full-year result was 27.75%, down 110.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 38.26%, down from 15.04% in the prior quarter.
- The five-year high for EBITDA Margin was 0.87% in Q4 2024, with the low at 57.51% in Q2 2022.
- Historically, EBITDA Margin has averaged 30.59% across 5 years, with a median of 32.37% in 2025.
- Annual changes were most pronounced in 2022 — EBITDA Margin sank 3790 bps — and 2023, when it soared 2787 bps.
- Treace Medical Concepts' EBITDA Margin stood at 8.92% in 2022, then decreased by 8 bps to 9.6% in 2023, then jumped by 91 bps to 0.87% in 2024, then slumped by 1637 bps to 15.04% in 2025, then sank by 154 bps to 38.26% in 2026.
- The last three EBITDA Margin figures came in at 38.26% (Q1 2026), 15.04% (Q4 2025), and 32.37% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Treace Medical Concepts | 274.20 Mn | 222.34 Mn | 37.41 Mn | -38.26% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.26% |
| Dec 31, 2025 | -15.04% |
| Sep 30, 2025 | -32.37% |
| Jun 30, 2025 | -36.73% |
| Mar 31, 2025 | -30.36% |
| Dec 31, 2024 | -0.87% |
| Sep 30, 2024 | -33.59% |
| Jun 30, 2024 | -47.92% |
| Mar 31, 2024 | -36.73% |
| Dec 31, 2023 | -9.60% |
| Sep 30, 2023 | -42.81% |
| Jun 30, 2023 | -29.64% |
| Mar 31, 2023 | -31.95% |
| Dec 31, 2022 | -8.92% |
| Sep 30, 2022 | -36.71% |
| Jun 30, 2022 | -57.51% |
| Mar 31, 2022 | -31.11% |
| Dec 31, 2021 | -16.74% |
| Sep 30, 2021 | -25.26% |
| Jun 30, 2021 | -19.61% |